IAPP and type 2 diabetes mellitus: In experimental models, antibody therapy has shown promising results: when applied to male rats and mice with human IAPP gene transfer, as well as in mouse models of T2D transplanted with human islets, the treatment successfully triggered the clearance of IAPP oligomers.